earnings
confidence high
sentiment positive
materiality 0.65
TransMedics Q3 revenue $108.8M (+64% YoY), net income $4.2M; FY guidance reaffirmed
TransMedics Group, Inc.
2024-Q3 EPS reported
$0.81
revenue$319,916,000
- Total revenue $108.8M, up 64% from $66.4M in Q3 2023.
- Net income $4.2M ($0.12 diluted EPS) vs net loss of $25.4M in prior year.
- Gross margin 56% vs 61% a year ago due to shift to service revenue.
- FY 2024 revenue guidance reaffirmed at $425M–$445M (76–84% growth).
- Cash $330.1M as of Sep 30; owned 18 aircraft for the National OCS Program.